Literature DB >> 18262730

Hybrid IMRT for treatment of cancers of the lung and esophagus.

Charles S Mayo1, Marcia M Urie, Thomas J Fitzgerald, Linda Ding, Yuan Chyuan Lo, Madeleine Bogdanov.   

Abstract

PURPOSE: To report on a hybrid intensity-modulated radiation therapy (IMRT; static plus IMRT beams treated concurrently) technique for lung and esophageal patients to reduce the volume of lung treated to low doses while delivering a conformal dose distribution.
METHODS: Treatment plans were analyzed for 18 patients (12 lung and 6 esophageal). Patients were treated with a hybrid technique that concurrently combines static (approximately two-thirds dose) and IMRT (approximately one-third dose) beams. These plans were compared with conventional three-dimensional (3D; non-IMRT) plans and all IMRT plans using custom four- and five-field arrangements and nine equally spaced coplanar beams. Plans were optimized to reduce V13 and V5 values. Dose-volume histograms were calculated for the planning target volume, heart, and the ipsilateral, contralateral, and total lung. Lung volumes V5, V13, V20, V30; mean lung dose (MLD); and the generalized equivalent uniform dose (gEUD) were calculated for each plan.
RESULTS: Hybrid plans treated significantly smaller total and contralateral lung volumes with low doses than nine-field IMRT plans. Largest reductions were for contralateral lung V5, V13, and V20 values for lung (-11%, -15%, -7%) and esophageal (-16%, -20%, -7%) patients. Smaller reductions were found also for 3D and four- and five-field IMRT plans. MLD and gEUDs were similar for all plan types. The 3D plans treated much larger extra planning target volumes to prescribed dose levels.
CONCLUSIONS: Hybrid IMRT demonstrated advantages for reduction of low-dose lung volumes in the thorax for reducing low dose to lung while also reducing the potential magnitude of dose deviations due to intrafraction motion and small field calculation accuracy.

Entities:  

Mesh:

Year:  2008        PMID: 18262730     DOI: 10.1016/j.ijrobp.2007.12.008

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  24 in total

Review 1.  Technological advances in radiotherapy for esophageal cancer.

Authors:  Milan Vosmik; Jiri Petera; Igor Sirak; Miroslav Hodek; Petr Paluska; Jiri Dolezal; Marcela Kopacova
Journal:  World J Gastroenterol       Date:  2010-11-28       Impact factor: 5.742

Review 2.  Intensity-Modulated Radiotherapy versus 3-Dimensional Conformal Radiotherapy Strategies for Locally Advanced Non-Small-Cell Lung Cancer.

Authors:  Uğur Selek; Yasemin Bölükbaşı; James W Welsh; Erkan Topkan
Journal:  Balkan Med J       Date:  2014-09-13       Impact factor: 2.021

3.  Is dose escalation achievable for esophageal carcinoma?

Authors:  Laure Vieillevigne; Marie Vidal; Françoise Izar; Michel Rives
Journal:  Rep Pract Oncol Radiother       Date:  2015-01-05

4.  AP-PA field orientation followed by IMRT reduces lung exposure in comparison to conventional 3D conformal and sole IMRT in centrally located lung tumors.

Authors:  Viacheslav Soyfer; Yaron Meir; Benjamin W Corn; Dan Schifter; Eliahu Gez; Haim Tempelhoff; Natan Shtraus
Journal:  Radiat Oncol       Date:  2012-02-16       Impact factor: 3.481

5.  Optimizing the flattening filter free beam selection in RapidArc®-based stereotactic body radiotherapy for Stage I lung cancer.

Authors:  J-Y Lu; Z Lin; P-X Lin; B-T Huang
Journal:  Br J Radiol       Date:  2015-07-02       Impact factor: 3.039

6.  Volumetric modulated arc therapy planning for distal oesophageal malignancies.

Authors:  M A Hawkins; J L Bedford; A P Warrington; D M Tait
Journal:  Br J Radiol       Date:  2011-03-22       Impact factor: 3.039

7.  Hybrid volumetric modulated arc therapy for whole breast irradiation: a dosimetric comparison of different arc designs.

Authors:  Velayudham Ramasubramanian; Karunakaran Balaji; Sitaraman Balaji Subramanian; Krishnamoorthi Sathiya; Moorthi Thirunavukarasu; Chandrasekaran Anu Radha
Journal:  Radiol Med       Date:  2019-01-30       Impact factor: 3.469

8.  Bayesian regression analyses of radiation modality effects on pericardial and pleural effusion and survival in esophageal cancer.

Authors:  Liru He; Andrew Chapple; Zhongxing Liao; Ritsuko Komaki; Peter F Thall; Steven H Lin
Journal:  Radiother Oncol       Date:  2016-08-22       Impact factor: 6.280

9.  Advanced techniques in neoadjuvant radiotherapy allow dose escalation without increased dose to the organs at risk : Planning study in esophageal carcinoma.

Authors:  K Fakhrian; M Oechsner; S Kampfer; T Schuster; M Molls; H Geinitz
Journal:  Strahlenther Onkol       Date:  2013-02-28       Impact factor: 3.621

10.  Clinical Application of a Hybrid RapidArc Radiotherapy Technique for Locally Advanced Lung Cancer.

Authors:  Scott R Silva; Murat Surucu; Jennifer Steber; Matthew M Harkenrider; Mehee Choi
Journal:  Technol Cancer Res Treat       Date:  2016-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.